Dr. James Martin’s Congenital Heart Disease Research Featured by Healio
Healio News interviewed Texas Heart Institute’s Dr. James Martin about his laboratory’s collaborative research study on congenital heart disease, performed with research...
James F. Martin MD PhD
Houston Chronicle Features Dr. James Martin’s Congenital Heart Disease Research
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
Collaborating to Develop A New Roadmap for Personalized Medicine
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options
Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
THI’s Dr. Rich Gang Li Wins Award at Weinstein Conference
Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...
Dr. Darren Woodside – Texas Heart Institute Vice President for Research – Receives Heralded Fellow Designation by the National Academy of Inventors
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
Groundbreaking Cardiovascular Gene Therapy Has Potential to Drastically Alter Outlook for Heart Failure Patients
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
Texas Heart Institute, Texas Children’s, and Baylor College of Medicine to Collaborate on Research to Improve Pediatric Heart Transplants
More than 450 children undergo a heart transplant in the United States each year. Despite incredible advances in the field...
